With the development, production and distribution of pharmaceutical specialties, we have been contributing to people’s health for more than 30 years. Our strengths include the development and manufacture of sterile liquid dosage forms and small molecule active pharmaceutical ingredients. For our own needs and as CDMO for third parties.
In Austria, we develop, produce and distribute some of the most established generic imaging agents under the Sanochemia brand. Our products help physicians make efficient therapeutic decisions for patients.
With contract manufacturing of sterile and low-bioburden liquids as well as APIs, we offer in-depth expertise in the field of drug product and API production. As a full-service provider, we also support with GMP services.
The registration initiative launched by Sanochemia Pharmazeutika in 2021, together with the continuously increasing market demand, has led to a record volume of orders.
Read moreSanochemia Pharmazeutika secures exclusive licensing rights to a new MRI contrast agent based on ferumoxtran, that is in an advanced pivotal trial in clinical phase III and may be used to detect the smallest lymph node metastases in prostate cancer patients. The product is already deployed in the Netherlands within an authorized Named-Patient-Use-Program (Artsenverklaring).
Read moreSanochemia Pharmazeutika is strengthening its position in the field of medical imaging with an exclusive product license for a MRI contrast agent based on iron-containing nanoparticles under the brand name Resotran®.
Read more
